Journal
CURRENT DIABETES REVIEWS
Volume 14, Issue 5, Pages 427-433Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573399813666170705161039
Keywords
Metabolic syndrome; dyslipidemia; insulin resistance; lipid metabolism; lipoprotein biosynthesis; microRNA
Categories
Ask authors/readers for more resources
Background: Metabolic syndrome is associated with increased risk for both type 2 diabetes and cardiovascular disease. Development of these pathologies is associated with the disorders of lipid and lipoprotein metabolism. Dyslipidemia leads to the overproduction of potentially atherogenic lipid and lipoproteins. Furthermore, there is a decrease in the levels of high-density lipoproteins and an increase in the levels of remnant and small dense LDL particles. Conclusion: In the current review, we have discussed the pathophysiology of lipoprotein biosynthesis and metabolism in the metabolic syndrome. Finally, we describe regulation of lipoprotein metabolism which may be used as a potential target for treating dyslipidemia in metabolic syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available